ACCESSIBILITY

24/7

Headlines

17:00

daily.dev raises $11 million in Seed funding to build a professional network for developers

12:15

"Only when women see themselves as decision makers of the future, will their situation change”

10:45

"Investments in Israel have all but disappeared - also because of the judicial coup”

08:20

Israeli startup is aiming to transform how cardiovascular disease is diagnosed and treated

Buzz

Most popular

Daily

Weekly

Check Point tells employees no raises in 2023

eToro value plummets, raises $250 million at $3.5 valuation

High-tech job market in crisis, isn't expected to rebound soon

TripleW raises $16.5 million Series B to produce lactic acid and bioplastic from food waste

Israeli startup raises $11 million to use generative AI to help developers test their code

More news

Pfizer

10 stories about Pfizer

מארק האפלה מנהל השקעות ראשי בחטיבת ניהול ההון של UBS

Mega-cap tech firms could lag the market next year, but tech in general won't underperform, says UBS chief investment officer

06.12.20|Sophie Shulman

Mark Haefele, Chief Investment Officer at UBS Global Wealth Management, says that stock markets will rise and fall depending on how quickly Covid-19 vaccines are approved and distributed

מנהל המכון הביולוגי נס ציונה פרופ' שמואל שפירא

“Excessive regulation” to blame for delay in Israeli Covid-19 vaccine says professor in charge

30.11.20|CTech

Director of the Israel Institute for Biological Research says vaccines will be distributed in the summer of 2021

New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist

24.11.20|Yafit Ovadia

“There isn’t any need for alarm,” says virologist about new coronavirus vaccines

After a coronavirus vaccine is approved, what happens next?

22.11.20|Sophie Shulman

On Dec. 10, the FDA is expected to announce whether it will approve Pfizer’s new vaccine, but 2 trillion people will not receive it until the end of 2021

מימין דרק זנוטו יבגני דיברוב ועידת ניו יורק

Markets may recover from pandemic soon, says CapitalG investor

17.11.20|CTech

Vaccine announcements, possible removal of U.S. travel ban and other factors will contribute to economic recovery, senior investors say in Calcalist and CTech’s Mind the Tech virtual conference

Moderna’s chief scientist says company initiated vaccine deal with Israel

16.11.20|Sophie Shulman

Israeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant

Pfizer and BioNTech claim 90% effective rate for their Covid-19 vaccine

09.11.20|Reuters

The news comes at the same time that Israel is currently undergoing human trials of its own vaccine for deployment in 2021

As the Covid-19 vaccine arms race intensifies, big money is at risk

10.08.20|Sophie Shulman

Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system

Place your bets: Which company will reach a Covid-19 vaccine first?

02.08.20|Sophie Shulman

Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game

בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

10.01.19|Lilach Baumer

Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars